LATAM Advanced Wound Care Market - Forecast To 2030
商品番号 : SMB-77033
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年4月 |
| ページ数 | 222 |
| 図表数 | 233 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The LATAM advanced wound care market is projected to reach USD 498.2 million by 2030 from USD 312.8 million in 2025, at a CAGR of 9.8% during the forecast period.
ラテンアメリカ（LATAM）の高度創傷ケア市場は、予測期間中に9.8%のCAGRで成長し、2025年の3億1,280万米ドルから2030年には4億9,820万米ドルに達すると予測されています。
The growth of the LATAM advanced wound care market is primarily driven by the rising incidence of chronic conditions that hinder wound healing, the growing geriatric population, and the emergence of age-related syndromes. The increasing prevalence of diabetes and obesity further accelerates this trend. Moreover, the surge in burn injuries, trauma cases, and road accidents has increased the demand for effective advanced wound care solutions. However, the high cost of advanced wound care products and the potential risks associated with their use pose challenges to market expansion. Despite these barriers, the ongoing development of healthcare infrastructure and the adoption of advanced technologies present substantial opportunities for market growth.
ラテンアメリカにおける高度創傷ケア市場の成長は、創傷治癒を阻害する慢性疾患の発症率上昇、高齢化人口の増加、そして加齢性症候群の出現が主な要因となっています。糖尿病と肥満の増加もこの傾向をさらに加速させています。さらに、火傷、外傷、交通事故の急増も、効果的な高度創傷ケアソリューションへの需要を高めています。しかしながら、高度創傷ケア製品の高コストと使用に伴う潜在的なリスクは、市場拡大の課題となっています。こうした障壁があるにもかかわらず、医療インフラの継続的な発展と先進技術の導入は、市場成長の大きな機会を生み出しています。
By end user, the hospitals & clinics segment of the LATAM advanced wound care market accounted for the largest market share in 2024.
Based on end users, the LATAM advanced wound care market is divided into hospitals & clinics, ambulatory surgery centers, home care settings, and other end users. In 2024, hospitals & clinics accounted for the largest share of the Latin American advanced wound care market due to their ability to manage a high volume of chronic and complex wound cases, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, as well as their advanced infrastructure, availability of specialized care, and rising hospital admissions linked to chronic wounds and hospital-acquired infections.
By application, the chronic wounds segment accounted for the largest market share of the LATAM advanced wound care market.
The LATAM advanced wound care market is segmented into acute and chronic wounds. The chronic wounds segment accounted for the largest market share in 2024, primarily due to the rising number of traffic accidents, workplace injuries, and other trauma-related incidents requiring immediate medical care. The increasing number of surgical procedures for chronic wounds and the importance of treatments for peri-operative wounds are also expected to contribute to the market growth of this segment.
The chronic wounds segment is further divided into diabetic foot ulcers, pressure ulcers, and other chronic wounds, each requiring specialized products for treatment. Diabetic foot ulcers and pressure ulcers are common & expensive, highlighting the critical nature of the market. Advanced wound care solutions are essential for managing chronic wounds, particularly for enhanced patient safety and efficient wound care procedures.
By region, Mexico is expected to grow at the highest CAGR during the forecast period.
The LATAM advanced wound care market is segmented into Brazil, Mexico, Argentina, Colombia, Peru, Chile, and the rest of Latin America. The market in Mexico is expected to grow at the highest CAGR during the forecast period, owing to the expansion of the geriatric population, the rising healthcare costs, and the increasing incidence of chronic wounds. Mexico is expected to grow at the highest CAGR of 11.8% during the forecast period. Additionally, the growing incidence of diabetes has led to a rise in diabetic foot ulcers, highlighting the significance of proper wound care. As wound care awareness improves and healthcare services advance, the demand for LATAM advanced wound care solutions in Mexico will contribute to market growth during the forecast period.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1−20%, Tier 2−45%, and Tier 3–35%
- By Designation: C-level–30%, Director-level–20% and Others–50%
- By Region: Brazil–35%, Mexico–25%, Argentina–10%, Chile- 8%, Colombia – 7%, Peru-5%, and the rest of Latin America–10%
Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The leading players operating in the LATAM advanced wound care market are Solventum (US), Smith+Nephew (UK), Cardinal Health (US), B. Braun SE (Germany), Mölnlycke AB (Sweden), Essity Aktiebolag (Sweden), Convatec Group PLC (UK), PAUL HARTMANN AG (Germany), Coloplast Group (Denmark), Integra LifeSciences Corporation (US), MATIV HOLDINGS, INC. (US), Owens & Minor (US), and AVERY DENNISON CORPORATION (US).
Research Coverage
This report studies the LATAM advanced wound care market based on product, wound type, end user, and country. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of the market segments relating to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established and entrants/smaller firms to gauge the market’s pulse, which, in turn, would help them gain a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.
This report provides insights into the following points:
- Analysis of Key DROCs: Drivers (the increasing incidence of chronic conditions impairing wound healing, the rising incidence of burn injuries, the growing number of trauma cases and road accidents); restraints (high cost of advanced wound care products, risk associated with advanced wound care products); opportunities (expansion of healthcare infrastructure & uptake of advanced technologies and universal health coverage); and challenges (shortage of skilled healthcare professionals, complications associated with delayed diagnosis, and limited awareness)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the LATAM advanced wound care market
- Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the LATAM advanced wound care market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the LATAM advanced wound care market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Table of Contents
1 INTRODUCTION 21
1.1 STUDY OBJECTIVES 21
1.2 MARKET DEFINITION 21
1.3 MARKET SCOPE 22
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 22
1.3.2 INCLUSIONS & EXCLUSIONS 23
1.3.3 YEARS CONSIDERED 23
1.3.4 CURRENCY CONSIDERED 24
1.4 STAKEHOLDERS 24
2 RESEARCH METHODOLOGY 25
2.1 RESEARCH DATA 25
2.1.1 SECONDARY DATA 26
2.1.1.1 Key data from secondary sources 27
2.1.2 PRIMARY DATA 27
2.1.2.1 Primary sources 28
2.1.2.2 Key industry insights 29
2.1.2.3 Key data from primary sources 29
2.1.2.4 Breakdown of primary interviews 30
2.2 MARKET SIZE ESTIMATION 31
2.2.1 BOTTOM-UP APPROACH 31
2.2.1.1 Approach 1: Company revenue estimation approach 31
2.2.1.2 Approach 2: Presentations of companies and primary interviews 32
2.2.1.3 Approach 3: Primary interviews 32
2.2.1.4 Growth forecast 32
2.2.1.5 CAGR projections 33
2.2.2 TOP-DOWN APPROACH 33
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 34
2.4 RESEARCH ASSUMPTIONS 36
2.4.1 STUDY-RELATED ASSUMPTIONS 36
2.4.2 PARAMETRIC ASSUMPTIONS 36
2.4.3 GROWTH RATE ASSUMPTIONS 36
2.5 RISK ASSESSMENT 37
2.6 RESEARCH LIMITATIONS 37
3 EXECUTIVE SUMMARY 38
4 PREMIUM INSIGHTS 42
4.1 LATAM ADVANCED WOUND CARE MARKET OVERVIEW 42
4.2 MEXICO: LATAM ADVANCED WOUND CARE MARKET,
BY END USER AND WOUND TYPE (2024) 43
4.3 LATAM ADVANCED WOUND CARE MARKET, BY KEY COUNTRY 44
4.4 COUNTRY MIX: LATAM ADVANCED WOUND CARE MARKET, 2024 45
5 MARKET OVERVIEW 46
5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 46
5.2.1 DRIVERS 47
5.2.1.1 Increasing incidence of chronic conditions impairing wound healing 47
5.2.1.1.1 Expansion of geriatric population and emergence of age-associated syndromes 47
5.2.1.1.2 Rising incidence of diabetes 47
5.2.1.1.3 Increasing cases of obesity 48
5.2.1.2 Growing number of burn injuries 49
5.2.1.3 Rising trauma cases and road accidents 49
5.2.2 RESTRAINTS 49
5.2.2.1 High cost of advanced wound care products 49
5.2.2.2 Risks associated with advanced wound care products 50
5.2.3 OPPORTUNITIES 51
5.2.3.1 Expansion of healthcare infrastructure and uptake of advanced technologies 51
5.2.3.2 Universal health coverage 51
5.2.4 CHALLENGES 51
5.2.4.1 Shortage of skilled healthcare professionals 51
5.2.4.2 Complications associated with delayed diagnosis and limited awareness 52
5.3 PRICING ANALYSIS 52
5.3.1 INDICATIVE PRICING OF KEY PLAYERS, BY APPLICATION (2025) 52
5.3.2 AVERAGE SELLING PRICE TREND, BY COUNTRY, 2023–2025 53
5.3.3 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023–2025 54
5.4 VALUE CHAIN ANALYSIS 54
5.4.1 RESEARCH & DEVELOPMENT (R&D) 54
5.4.2 MANUFACTURING 54
5.4.3 DISTRIBUTION AND MARKETING & SALES 54
5.4.4 POST-SALES SERVICES 55
5.5 SUPPLY CHAIN ANALYSIS 55
5.5.1 PROMINENT COMPANIES 55
5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES 55
5.5.3 END USERS 56
5.6 ECOSYSTEM ANALYSIS 56
5.7 PORTER’S FIVE FORCES ANALYSIS 57
5.7.1 THREAT OF NEW ENTRANTS 59
5.7.2 THREAT OF SUBSTITUTES 59
5.7.3 BARGAINING POWER OF SUPPLIERS 59
5.7.4 BARGAINING POWER OF BUYERS 59
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 59
5.8 REGULATORY ANALYSIS 60
5.8.1 REGULATORY LANDSCAPE 60
5.8.1.1 Brazil 60
5.8.1.2 Mexico 60
5.8.1.3 Colombia 60
5.8.1.4 Argentina 61
5.8.1.5 Peru 61
5.8.1.6 Chile 62
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
5.9 TECHNOLOGY ANALYSIS 63
5.9.1 KEY TECHNOLOGIES 63
5.9.1.1 Portable Negative Pressure Wound Therapy (NPWT) devices 63
5.9.2 ADJACENT TECHNOLOGIES 64
5.9.2.1 Telemedicine for wound care 64
5.9.3 COMPLEMENTARY TECHNOLOGIES 64
5.9.3.1 Antimicrobial wound dressings 64
5.10 TRADE ANALYSIS 65
5.10.1 TRADE ANALYSIS FOR ADHESIVE DRESSINGS 65
5.11 PATENT ANALYSIS 66
5.12 KEY CONFERENCES & EVENTS, 2025 67
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 68
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 68
5.14.2 BUYING CRITERIA 69
5.15 IMPACT OF AI/GENERATIVE AI ON LATAM ADVANCED WOUND CARE MARKET 69
5.15.1 INTRODUCTION 69
5.15.2 POTENTIAL OF AI IN ADVANCED WOUND CARE 69
5.15.3 AI USE CASES 70
5.15.4 FUTURE OF GENERATIVE AI ON ADVANCED WOUND CARE 71
5.16 INVESTMENT & FUNDING SCENARIO 71
5.17 CASE STUDY ANALYSIS 72
5.17.1 CASE STUDY 1: EFFECTIVE WOUND MANAGEMENT WITH BIATAIN SILICONE 72
5.17.2 CASE STUDY 2: ENHANCING WOUND CARE WITH MEPILEX UP 72
5.17.3 CASE STUDY 3: HYDROCOLL HYDROCOLLOID DRESSING SUPPORTS WOUND HEALING 73
6 LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT 74
6.1 INTRODUCTION 75
6.2 FOAM DRESSINGS 75
6.2.1 SILICON DRESSINGS 77
6.2.1.1 Bordered silicon dressings 78
6.2.1.1.1 Gentle adhesive qualities to fuel uptake 78
6.2.1.2 Non-bordered silicon dressings 79
6.2.1.2.1 Highly absorbent foam core to boost adoption 79
6.2.2 NON-SILICON DRESSINGS 80
6.2.2.1 High comfort and conformability to boost market 80
6.2.3 XEROFORM DRESSINGS 81
6.2.3.1 Provision of bacteriostatic properties to fuel greater demand 81
6.2.4 HYDROCOLLOID DRESSINGS 82
6.2.4.1 Increased functionality and enhanced collagen synthesis to drive market 82
6.2.5 FILM DRESSINGS 83
6.2.5.1 Transparent and elastic properties to fuel uptake 83
6.2.6 ALGINATE DRESSINGS 84
6.2.6.1 High incidence of burn injuries to boost market 84
6.2.7 GELLING DRESSINGS 86
6.2.7.1 Effective management of moderate to heavy exuding wounds to support market growth 86
6.2.8 COLLAGEN DRESSINGS 87
6.2.8.1 Inflammatory control and facilitation of protein synthesis to drive market 87
6.2.9 OTHER ADVANCED DRESSINGS 88
7 LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE 90
7.1 INTRODUCTION 91
7.2 CHRONIC WOUNDS 92
7.2.1 DIABETIC FOOT ULCERS 93
7.2.1.1 Increasing prevalence of diabetes to drive market 93
7.2.2 PRESSURE ULCERS 95
7.2.2.1 Rising geriatric population and subsequent increase in comorbidities to fuel market 95
7.2.3 VENOUS LEG ULCERS 96
7.2.3.1 Increasing prevalence of obesity to support market growth 96
7.2.4 OTHER CHRONIC WOUNDS 97
7.3 ACUTE WOUNDS 98
7.3.1 SURGICAL & TRAUMATIC WOUNDS 99
7.3.1.1 Increasing volume of surgical procedures due to trauma & road accidents to fuel market 99
7.3.2 BURNS 100
7.3.2.1 High incidence of burn injuries to support market growth 100
8 LATAM ADVANCED WOUND CARE MARKET, BY END USER 102
8.1 INTRODUCTION 103
8.2 HOSPITALS & CLINICS 103
8.2.1 RISING INCIDENCE OF HAIS TO DRIVE MARKET 103
8.3 AMBULATORY SURGERY CENTERS 105
8.3.1 PROVISION OF SPECIALIZED WOUND CARE SERVICES TO PROPEL MARKET 105
8.4 HOME CARE SETTINGS 106
8.4.1 LOW COSTS AND CONVENIENCE TO BOOST DEMAND 106
8.5 OTHER END USERS 107
9 LATAM ADVANCED WOUND CARE MARKET, BY COUNTRY 109
9.1 INTRODUCTION 110
9.2 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 110
9.2.1 BRAZIL 111
9.2.1.1 Large healthcare sector to fuel demand 111
9.2.2 MEXICO 116
9.2.2.1 Rising incidence of diabetes and chronic wounds to propel market 116
9.2.3 COLOMBIA 120
9.2.3.1 Increasing incidence of venous ulcers to boost demand 120
9.2.4 ARGENTINA 124
9.2.4.1 Increasing cases of burn injuries and trauma cases to support market growth 124
9.2.5 PERU 128
9.2.5.1 Growing requirement for efficient wound healing management due to shortage of skilled professionals to fuel market 128
9.2.6 CHILE 132
9.2.6.1 Improvements in healthcare infrastructure to support market growth 132
9.2.7 REST OF LATIN AMERICA 135
10 COMPETITIVE LANDSCAPE 139
10.1 OVERVIEW 139
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024 139
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATAM ADVANCED WOUND CARE MARKET 139
10.3 REVENUE ANALYSIS, 2021−2023 140
10.4 MARKET SHARE ANALYSIS, 2024 141
10.5 COMPANY VALUATION AND FINANCIAL METRICS 144
10.5.1 COMPANY VALUATION 144
10.5.2 FINANCIAL METRICS 144
10.6 BRAND/PRODUCT COMPARISON 145
10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 145
10.7.1 STARS 146
10.7.2 EMERGING LEADERS 146
10.7.3 PERVASIVE PLAYERS 146
10.7.4 PARTICIPANTS 146
10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 148
10.7.5.1 Company footprint 148
10.7.5.2 Region footprint 149
10.7.5.3 Product footprint 150
10.7.5.4 Wound type footprint 151
10.7.5.5 End-user footprint 152
10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 153
10.8.1 PROGRESSIVE COMPANIES 153
10.8.2 RESPONSIVE COMPANIES 153
10.8.3 DYNAMIC COMPANIES 153
10.8.4 STARTING BLOCKS 153
10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 154
10.8.5.1 Detailed list of key startups/SMEs 154
10.8.5.2 Competitive benchmarking of key startups/SMEs 155
10.9 COMPETITIVE SCENARIO 156
10.9.1 PRODUCT LAUNCHES 156
10.9.2 DEALS 156
10.9.3 EXPANSIONS 157
10.9.4 OTHER DEVELOPMENTS 158
11 COMPANY PROFILES 159
11.1 KEY PLAYERS 159
11.1.1 SOLVENTUM 159
11.1.1.1 Business overview 159
11.1.1.2 Products offered 160
11.1.1.3 Recent developments 161
11.1.1.3.1 Other developments 161
11.1.1.4 MnM view 162
11.1.1.4.1 Right to win 162
11.1.1.4.2 Strategic choices 162
11.1.1.4.3 Weaknesses & competitive threats 162
11.1.2 MÖLNLYCKE AB 163
11.1.2.1 Business overview 163
11.1.2.2 Products offered 165
11.1.2.3 Recent developments 166
11.1.2.3.1 Deals 166
11.1.2.4 MnM view 166
11.1.2.4.1 Right to win 166
11.1.2.4.2 Strategic choices 166
11.1.2.4.3 Weaknesses & competitive threats 166
11.1.3 COLOPLAST GROUP 167
11.1.3.1 Business overview 167
11.1.3.2 Products offered 168
11.1.3.3 Recent developments 169
11.1.3.3.1 Deals 169
11.1.3.4 MnM view 169
11.1.3.4.1 Right to win 169
11.1.3.4.2 Strategic choices 169
11.1.3.4.3 Weaknesses & competitive threats 169
11.1.4 SMITH+NEPHEW 170
11.1.4.1 Business overview 170
11.1.4.2 Products offered 171
11.1.4.3 Recent developments 172
11.1.4.3.1 Deals 172
11.1.4.3.2 Expansions 173
11.1.4.3.3 Other developments 173
11.1.4.4 MnM view 174
11.1.4.4.1 Right to win 174
11.1.4.4.2 Strategic choices 174
11.1.4.4.3 Weaknesses & competitive threats 174
11.1.5 CONVATEC GROUP PLC 175
11.1.5.1 Business overview 175
11.1.5.2 Products offered 176
11.1.5.3 Recent developments 177
11.1.5.3.1 Product launches/approvals/enhancements 177
11.1.5.3.2 Deals 177
11.1.5.4 MnM view 178
11.1.5.4.1 Right to win 178
11.1.5.4.2 Strategic choices 178
11.1.5.4.3 Weaknesses & competitive threats 178
11.1.6 CARDINAL HEALTH 179
11.1.6.1 Business overview 179
11.1.6.2 Products offered 180
11.1.6.3 Recent developments 181
11.1.6.3.1 Expansions 181
11.1.7 B. BRAUN SE 183
11.1.7.1 Business overview 183
11.1.7.2 Products offered 184
11.1.7.3 Recent developments 185
11.1.7.3.1 Deals 185
11.1.7.3.2 Expansions 185
11.1.8 ESSITY AKTIEBOLAG 186
11.1.8.1 Business overview 186
11.1.8.2 Products offered 187
11.1.8.3 Recent developments 188
11.1.8.3.1 Deals 188
11.1.8.3.2 Expansions 188
11.1.9 PAUL HARTMANN AG 189
11.1.9.1 Business overview 189
11.1.9.2 Products offered 190
11.1.9.3 Recent developments 191
11.1.9.3.1 Deals 191
11.1.10 INTEGRA LIFESCIENCES CORPORATION 192
11.1.10.1 Business overview 192
11.1.10.2 Products offered 193
11.1.10.3 Recent developments 194
11.1.10.3.1 Deals 194
11.1.10.3.2 Expansions 194
11.1.11 MATIV HOLDINGS, INC. 195
11.1.11.1 Business overview 195
11.1.11.2 Products offered 196
11.1.11.3 Recent developments 197
11.1.11.3.1 Deals 197
11.1.12 OWENS & MINOR 198
11.1.12.1 Business overview 198
11.1.12.2 Products offered 199
11.1.12.3 Recent developments 200
11.1.12.3.1 Deals 200
11.1.13 AVERY DENNISON CORPORATION 202
11.1.13.1 Business overview 202
11.1.13.2 Products offered 203
11.1.13.3 Recent developments 204
11.1.13.3.1 Deals 204
11.1.13.3.2 Expansions 204
11.2 OTHER PLAYERS 205
11.2.1 LOHMANN & RAUSCHER GMBH & CO. KG 205
11.2.2 MEDLINE INDUSTRIES, LP 206
11.2.3 FERRIS MFG. CORP. 207
11.2.4 TRIAGE MEDTECH 207
11.2.5 MISSNER & MISSNER LTDA 208
11.2.6 DEROYAL INDUSTRIES, INC. 209
11.2.7 HOLLISTER INCORPORATED 210
11.2.8 WINNER MEDICAL CO., LTD. 211
11.2.9 URGO MEDICAL 212
11.2.10 BAIHE MEDICAL 212
11.2.11 CREMER S.A. 213
11.2.12 ADVANCIS (UK) 214
12 APPENDIX 215
12.1 DISCUSSION GUIDE 215
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 218
12.3 CUSTOMIZATION OPTIONS 220
12.4 RELATED REPORTS 220
12.5 AUTHOR DETAILS 221
LIST OF TABLES
TABLE 1 LATAM ADVANCED WOUND CARE MARKET: INCLUSIONS & EXCLUSIONS 23
TABLE 2 LATAM ADVANCED WOUND CARE WOUND CARE MARKET: RISK ASSESSMENT 37
TABLE 3 PEOPLE WITH DIABETES (20–79 YEARS), BY COUNTRY,
2021 VS. 2045 (IN THOUSANDS) 48
TABLE 4 PREVALENCE OF OVERWEIGHT ADULTS, BMI ≥ 25 KG/M² (AGE-STANDARDIZED ESTIMATE) (%); 18+ YEARS IN LATIN AMERICA, MALE & FEMALE 48
TABLE 5 AVERAGE TREATMENT COST FOR DIABETIC FOOT ULCERS 50
TABLE 6 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS 50
TABLE 7 INDICATIVE PRICE OF KEY PLAYERS FOR WOUND TYPE IN 2025 (USD) 53
TABLE 8 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY COUNTRY, 2023–2025 53
TABLE 9 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023–2025 54
TABLE 10 LATAM ADVANCED WOUND CARE MARKET: ROLE IN ECOSYSTEM 57
TABLE 11 LATAM ADVANCED WOUND CARE MARKET: PORTER’S FIVE FORCES ANALYSIS 58
TABLE 12 LATIN AMERICA: LIST OF KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
TABLE 13 IMPORT DATA FOR ADHESIVE DRESSINGS, BY COUNTRY,
2020–2024 (USD MILLION) 65
TABLE 14 EXPORT DATA FOR ADHESIVE DRESSINGS, BY COUNTRY,
2020–2024 (USD MILLION) 65
TABLE 15 LATAM ADVANCED WOUND CARE MARKET: KEY CONFERENCES & EVENTS, 2025 67
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 68
TABLE 17 KEY BUYING CRITERIA FOR ADVANCED WOUND CARE PRODUCTS, BY RANK 69
TABLE 18 LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 75
TABLE 19 KEY PRODUCTS OFFERED IN FOAM DRESSINGS MARKET 76
TABLE 20 LATAM ADVANCED WOUND CARE MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 76
TABLE 21 LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 77
TABLE 22 LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY COUNTRY, 2022–2030 (USD MILLION) 77
TABLE 23 LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 78
TABLE 24 LATAM ADVANCED WOUND CARE MARKET FOR BORDERED DRESSINGS,
BY COUNTRY, 2022–2030 (USD MILLION) 79
TABLE 25 LATAM ADVANCED WOUND CARE MARKET FOR NON-BORDERED SILICON DRESSINGS, BY COUNTRY, 2022–2030 (USD MILLION) 80
TABLE 26 LATAM ADVANCED WOUND CARE MARKET FOR NON-SILICON DRESSINGS,
BY COUNTRY, 2022–2030 (USD MILLION) 81
TABLE 27 KEY PRODUCTS OFFERED IN XEROFORM DRESSINGS MARKET 81
TABLE 28 LATAM ADVANCED WOUND CARE MARKET FOR XEROFORM DRESSINGS,
BY COUNTRY, 2022–2030 (USD MILLION) 82
TABLE 29 KEY PRODUCTS OFFERED IN HYDROCOLLOID DRESSINGS MARKET 83
TABLE 30 LATAM ADVANCED WOUND CARE MARKET FOR HYDROCOLLOID DRESSINGS,
BY COUNTRY, 2022–2030 (USD MILLION) 83
TABLE 31 KEY PRODUCTS OFFERED IN FILM DRESSINGS MARKET 84
TABLE 32 LATAM ADVANCED WOUND CARE MARKET FOR FILM DRESSINGS, BY COUNTRY, 2022–2030 (USD MILLION) 84
TABLE 33 KEY PRODUCTS OFFERED IN ALGINATE DRESSINGS MARKET 85
TABLE 34 LATAM ADVANCED WOUND CARE MARKET FOR ALGINATE DRESSINGS,
BY COUNTRY, 2022–2030 (USD MILLION) 85
TABLE 35 KEY PRODUCTS OFFERED IN GELLING DRESSINGS MARKET 86
TABLE 36 LATAM ADVANCED WOUND CARE MARKET FOR GELLING DRESSINGS,
BY COUNTRY, 2022–2030 (USD MILLION) 86
TABLE 37 KEY PRODUCTS OFFERED IN COLLAGEN DRESSINGS MARKET 87
TABLE 38 LATAM ADVANCED WOUND CARE MARKET FOR COLLAGEN DRESSINGS,
BY COUNTRY, 2022–2030 (USD MILLION) 88
TABLE 39 OTHER ADVANCED DRESSINGS OFFERED 89
TABLE 40 LATAM ADVANCED WOUND CARE MARKET FOR OTHER ADVANCED DRESSINGS,
BY COUNTRY, 2022–2030 (USD MILLION) 89
TABLE 41 LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE,
2022–2030 (USD MILLION) 91
TABLE 42 CHRONIC WOUNDS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 91
TABLE 43 ACUTE WOUNDS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 92
TABLE 44 CHRONIC WOUNDS MARKET, BY TYPE, 2022–2030 (USD MILLION) 93
TABLE 45 PREVALENCE OF DIABETES IN LATIN AMERICA, BY COUNTRY (2021) 94
TABLE 46 CHRONIC WOUNDS MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY,
2022–2030 (USD MILLION) 94
TABLE 47 NUMBER OF ADULT PATIENTS WITH DIABETIC FOOT ULCERS (THOUSANDS) 95
TABLE 48 CHRONIC WOUNDS MARKET FOR PRESSURE ULCERS, BY COUNTRY,
2022–2030 (USD MILLION) 96
TABLE 49 CHRONIC WOUNDS MARKET FOR VENOUS LEG ULCERS, BY COUNTRY,
2022–2030 (USD MILLION) 97
TABLE 50 OTHER CHRONIC WOUNDS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 98
TABLE 51 ACUTE WOUNDS MARKET, BY TYPE, 2022–2030 (USD MILLION) 98
TABLE 52 ACUTE WOUNDS MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2022–2030 (USD MILLION) 100
TABLE 53 ACUTE WOUNDS MARKET FOR BURNS, BY COUNTRY, 2022–2030 (USD MILLION) 101
TABLE 54 LATAM ADVANCED WOUND CARE MARKET, BY END USER,
2022–2030 (USD MILLION) 103
TABLE 55 HOSPITALS PER CAPITA, BY COUNTRY (2025) 104
TABLE 56 LATAM ADVANCED WOUND CARE MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2022–2030 (USD MILLION) 104
TABLE 57 LATAM ADVANCED WOUND CARE MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2030 (USD MILLION) 105
TABLE 58 LATAM ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2022–2030 (USD MILLION) 107
TABLE 59 LATAM ADVANCED WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION) 108
TABLE 60 LATIN AMERICA: MACROECONOMIC INDICATORS 110
TABLE 61 LATAM ADVANCED WOUND CARE MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 111
TABLE 62 BRAZIL: MACROECONOMIC INDICATORS 112
TABLE 63 BRAZIL: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 114
TABLE 64 BRAZIL: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS,
BY TYPE, 2022–2030 (USD MILLION) 114
TABLE 65 BRAZIL: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS,
BY TYPE, 2022–2030 (USD MILLION) 115
TABLE 66 BRAZIL: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE,
2022–2030 (USD MILLION) 115
TABLE 67 BRAZIL: CHRONIC WOUNDS MARKET, BY WOUND TYPE,
2022–2030 (USD MILLION) 115
TABLE 68 BRAZIL: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 116
TABLE 69 BRAZIL: LATAM ADVANCED WOUND CARE MARKET, BY END USER,
2022–2030 (USD MILLION) 116
TABLE 70 MEXICO: MACROECONOMIC INDICATORS 117
TABLE 71 MEXICO: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 118
TABLE 72 MEXICO: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS,
BY TYPE, 2022–2030 (USD MILLION) 118
TABLE 73 MEXICO: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS,
BY TYPE, 2022–2030 (USD MILLION) 119
TABLE 74 MEXICO: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE,
2022–2030 (USD MILLION) 119
TABLE 75 MEXICO: CHRONIC WOUNDS MARKET, BY WOUND TYPE,
2022–2030 (USD MILLION) 119
TABLE 76 MEXICO: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 120
TABLE 77 MEXICO: LATAM ADVANCED WOUND CARE MARKET, BY END USER,
2022–2030 (USD MILLION) 120
TABLE 78 COLOMBIA: MACROECONOMIC INDICATORS 121
TABLE 79 COLOMBIA: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 122
TABLE 80 COLOMBIA: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS,
BY TYPE, 2022–2030 (USD MILLION) 122
TABLE 81 COLOMBIA: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 123
TABLE 82 COLOMBIA: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE,
2022–2030 (USD MILLION) 123
TABLE 83 COLOMBIA: CHRONIC WOUNDS MARKET, BY WOUND TYPE,
2022–2030 (USD MILLION) 123
TABLE 84 COLOMBIA: ACUTE WOUNDS MARKET, BY WOUND TYPE,
2022–2030 (USD MILLION) 124
TABLE 85 COLOMBIA: LATAM ADVANCED WOUND CARE MARKET, BY END USER,
2022–2030 (USD MILLION) 124
TABLE 86 ARGENTINA: MACROECONOMIC INDICATORS 125
TABLE 87 ARGENTINA: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 126
TABLE 88 ARGENTINA: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS,
BY TYPE, 2022–2030 (USD MILLION) 126
TABLE 89 ARGENTINA: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 127
TABLE 90 ARGENTINA: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE,
2022–2030 (USD MILLION) 127
TABLE 91 ARGENTINA: CHRONIC WOUNDS MARKET, BY WOUND TYPE,
2022–2030 (USD MILLION) 127
TABLE 92 ARGENTINA: ACUTE WOUNDS MARKET, BY WOUND TYPE,
2022–2030 (USD MILLION) 128
TABLE 93 ARGENTINA: LATAM ADVANCED WOUND CARE MARKET, BY END USER,
2022–2030 (USD MILLION) 128
TABLE 94 PERU: MACROECONOMIC INDICATORS 129
TABLE 95 PERU: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 129
TABLE 96 PERU: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 130
TABLE 97 PERU: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS,
BY TYPE, 2022–2030 (USD MILLION) 130
TABLE 98 PERU: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE,
2022–2030 (USD MILLION) 130
TABLE 99 PERU: CHRONIC WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 131
TABLE 100 PERU: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 131
TABLE 101 PERU: LATAM ADVANCED WOUND CARE MARKET, BY END USER,
2022–2030 (USD MILLION) 131
TABLE 102 CHILE: MACROECONOMIC INDICATORS 132
TABLE 103 CHILE: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 133
TABLE 104 CHILE: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS,
BY TYPE, 2022–2030 (USD MILLION) 133
TABLE 105 CHILE: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS,
BY TYPE, 2022–2030 (USD MILLION) 134
TABLE 106 CHILE: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE,
2022–2030 (USD MILLION) 134
TABLE 107 CHILE: CHRONIC WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 134
TABLE 108 CHILE: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 135
TABLE 109 CHILE: LATAM ADVANCED WOUND CARE MARKET, BY END USER,
2022–2030 (USD MILLION) 135
TABLE 110 REST OF LATIN AMERICA: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 136
TABLE 111 REST OF LATIN AMERICA: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 136
TABLE 112 REST OF LATIN AMERICA: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 137
TABLE 113 REST OF LATIN AMERICA: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 137
TABLE 114 REST OF LATIN AMERICA: CHRONIC WOUNDS MARKET, BY WOUND TYPE,
2022–2030 (USD MILLION) 137
TABLE 115 REST OF LATIN AMERICA: ACUTE WOUNDS MARKET, BY WOUND TYPE,
2022–2030 (USD MILLION) 138
TABLE 116 REST OF LATIN AMERICA: LATAM ADVANCED WOUND CARE MARKET,
BY END USER, 2022–2030 (USD MILLION) 138
TABLE 117 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATAM ADVANCED WOUND CARE MARKET, 2022–2025 139
TABLE 118 LATAM ADVANCED WOUND CARE MARKET: DEGREE OF COMPETITION 142
TABLE 119 LATAM ADVANCED WOUND CARE MARKET: REGION FOOTPRINT 149
TABLE 120 LATAM ADVANCED WOUND CARE MARKET: PRODUCT FOOTPRINT 150
TABLE 121 LATAM ADVANCED WOUND CARE MARKET: WOUND TYPE FOOTPRINT 151
TABLE 122 LATAM ADVANCED WOUND CARE MARKET: END-USER FOOTPRINT 152
TABLE 123 LATAM ADVANCED WOUND CARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 154
TABLE 124 LATAM ADVANCED WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 155
TABLE 125 LATAM ADVANCED WOUND CARE MARKET: PRODUCT LAUNCHES,
JANUARY 2022–FEBRUARY 2025 156
TABLE 126 LATAM ADVANCED WOUND CARE MARKET: DEALS,
JANUARY 2022–FEBRUARY 2025 156
TABLE 127 LATAM ADVANCED WOUND CARE MARKET: EXPANSIONS,
JANUARY 2022–FEBRUARY 2025 157
TABLE 128 LATAM ADVANCED WOUND CARE MARKET: OTHER DEVELOPMENTS,
JANUARY 2022−FEBRUARY 2025 158
TABLE 129 SOLVENTUM: COMPANY OVERVIEW 159
TABLE 130 SOLVENTUM: PRODUCTS OFFERED 160
TABLE 131 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2021–FEBRUARY 2025 161
TABLE 132 MÖLNLYCKE AB: COMPANY OVERVIEW 163
TABLE 133 MÖLNLYCKE AB: PRODUCTS OFFERED 165
TABLE 134 MÖLNLYCKE AB: DEALS, JANUARY 2021–FEBRUARY 2025 166
TABLE 135 COLOPLAST GROUP: COMPANY OVERVIEW 167
TABLE 136 COLOPLAST GROUP: PRODUCTS OFFERED 168
TABLE 137 COLOPLAST GROUP: DEALS, JANUARY 2021–FEBRUARY 2025 169
TABLE 138 SMITH+NEPHEW: COMPANY OVERVIEW 170
TABLE 139 SMITH+NEPHEW: PRODUCTS OFFERED 171
TABLE 140 SMITH+NEPHEW: DEALS, JANUARY 2021–FEBRUARY 2025 172
TABLE 141 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021–FEBRUARY 2025 173
TABLE 142 SMITH+NEPHEW: OTHER DEVELOPMENTS, JANUARY 2021–FEBRUARY 2025 173
TABLE 143 CONVATEC GROUP PLC: COMPANY OVERVIEW 175
TABLE 144 CONVATEC GROUP PLC: PRODUCTS OFFERED 176
TABLE 145 CONVATEC GROUP PLC: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS, JANUARY 2021–FEBRUARY 2025 177
TABLE 146 CONVATEC GROUP PLC: DEALS, JANUARY 2021–FEBRUARY 2025 177
TABLE 147 CARDINAL HEALTH: COMPANY OVERVIEW 179
TABLE 148 CARDINAL HEALTH: PRODUCTS OFFERED 180
TABLE 149 CARDINAL HEALTH: EXPANSIONS, JANUARY 2021–FEBRUARY 2025 181
TABLE 150 B. BRAUN SE: COMPANY OVERVIEW 183
TABLE 151 B. BRAUN SE: PRODUCTS OFFERED 184
TABLE 152 B. BRAUN SE: DEALS, JANUARY 2021–FEBRUARY 2025 185
TABLE 153 B. BRAUN SE: EXPANSIONS, JANUARY 2021–FEBRUARY 2025 185
TABLE 154 ESSITY AKTIEBOLAG: COMPANY OVERVIEW 186
TABLE 155 ESSITY AKTIEBOLAG: PRODUCTS OFFERED 187
TABLE 156 ESSITY AKTIEBOLAG: DEALS, JANUARY 2021–FEBRUARY 2025 188
TABLE 157 ESSITY AKTIEBOLAG: EXPANSIONS, JANUARY 2021–FEBRUARY 2025 188
TABLE 158 PAUL HARTMANN AG: COMPANY OVERVIEW 189
TABLE 159 PAUL HARTMANN AG: PRODUCTS OFFERED 190
TABLE 160 PAUL HARTMANN AG: DEALS, JANUARY 2021–FEBRUARY 2025 191
TABLE 161 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 192
TABLE 162 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED 193
TABLE 163 INTEGRA LIFESCIENCES: DEALS JANUARY 2021–FEBRUARY 2025 194
TABLE 164 INTEGRA LIFESCIENCES CORPORATION: EXPANSIONS,
JANUARY 2021–FEBRUARY 2025 194
TABLE 165 MATIV HOLDINGS, INC.: COMPANY OVERVIEW 195
TABLE 166 MATIV HOLDINGS, INC.: PRODUCTS OFFERED 196
TABLE 167 MATIV HOLDINGS, INC.: DEALS, JANUARY 2021–FEBRUARY 2025 197
TABLE 168 OWENS & MINOR: COMPANY OVERVIEW 198
TABLE 169 OWENS & MINOR: PRODUCTS OFFERED 199
TABLE 170 OWENS & MINOR: DEALS, JANUARY 2021–FEBRUARY 2025 200
TABLE 171 AVERY DENNISON CORPORATION: COMPANY OVERVIEW 202
TABLE 172 AVERY DENNISON CORPORATION: PRODUCTS OFFERED 203
TABLE 173 AVERY DENNISON CORPORATION: DEALS, JANUARY 2021–FEBRUARY 2025 204
TABLE 174 AVERY DENNISON CORPORATION: EXPANSIONS, JANUARY 2021–FEBRUARY 2025 204
TABLE 175 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW 205
TABLE 176 MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW 206
TABLE 177 FERRIS MFG. CORP.: COMPANY OVERVIEW 207
TABLE 178 TRIAGE MEDTECH: COMPANY OVERVIEW 207
TABLE 179 MISSNER & MISSNER LTDA: COMPANY OVERVIEW 208
TABLE 180 DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW 209
TABLE 181 HOLLISTER INCORPORATED: COMPANY OVERVIEW 210
TABLE 182 WINNER MEDICAL CO., LTD.: COMPANY OVERVIEW 211
TABLE 183 URGO MEDICA: COMPANY OVERVIEW 212
TABLE 184 BAIHE MEDICAL: COMPANY OVERVIEW 212
TABLE 185 CREMER S.A.: COMPANY OVERVIEW 213
TABLE 186 ADVANCIS (UK): COMPANY OVERVIEW 214
LIST OF FIGURES
FIGURE 1 LATAM ADVANCED WOUND CARE MARKET: RESEARCH DESIGN 25
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND COUNTRIES 30
FIGURE 3 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 31
FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 33
FIGURE 5 LATAM ADVANCED WOUND CARE MARKET: TOP-DOWN APPROACH 33
FIGURE 6 DATA TRIANGULATION METHODOLOGY 35
FIGURE 7 LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT,
2025 VS. 2030 (USD MILLION) 38
FIGURE 8 LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE,
2025 VS. 2030 (USD MILLION) 39
FIGURE 9 LATAM ADVANCED WOUND CARE MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 40
FIGURE 10 GEOGRAPHIC SNAPSHOT OF LATAM ADVANCED WOUND CARE MARKET 41
FIGURE 11 RISING INCIDENCE OF CHRONIC CONDITIONS AND AGE-ASSOCIATED SYNDROMES TO FUEL MARKET 42
FIGURE 12 HOSPITALS & CLINICS SEGMENT ACCOUNTED FOR LARGEST
MARKET SHARE IN 2024 43
FIGURE 13 MEXICO TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030 44
FIGURE 14 BRAZIL ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 45
FIGURE 15 LATAM ADVANCED WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
FIGURE 16 LATAM ADVANCED WOUND CARE MARKET: VALUE CHAIN ANALYSIS 55
FIGURE 17 LATAM ADVANCED WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS 56
FIGURE 18 LATAM ADVANCED WOUND CARE MARKET: ECOSYSTEM ANALYSIS 57
FIGURE 19 LATAM ADVANCED WOUND CARE MARKET: PORTER’S FIVE FORCES ANALYSIS 58
FIGURE 20 LATAM ADVANCED WOUND CARE MARKET: PATENT ANALYSIS,
JANUARY 2015–MARCH 2024 66
FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67
FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 68
FIGURE 23 KEY BUYING CRITERIA FOR ADVANCED WOUND CARE PRODUCTS, BY END USER 69
FIGURE 24 INVESTMENT & FUNDING SCENARIO, 2020−2025 71
FIGURE 25 BRAZIL: LATAM ADVANCED WOUND CARE MARKET SNAPSHOT 113
FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS, 2021−2023 (USD MILLION) 141
FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 142
FIGURE 28 RANKING OF KEY PLAYERS IN LATAM ADVANCED WOUND CARE MARKET, 2024 143
FIGURE 29 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS, 2025 144
FIGURE 30 FINANCIAL METRICS, 2025 144
FIGURE 31 LATAM ADVANCED WOUND CARE MARKET: BRAND/PRODUCT COMPARISON 145
FIGURE 32 LATAM ADVANCED WOUND CARE MARKET: COMPANY
EVALUATION MATRIX (KEY PLAYERS), 2024 147
FIGURE 33 LATAM ADVANCED WOUND CARE MARKET: COMPANY FOOTPRINT 148
FIGURE 34 LATAM ADVANCED WOUND CARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 154
FIGURE 35 SOLVENTUM: COMPANY SNAPSHOT (2024) 160
FIGURE 36 MÖLNLYCKE AB: COMPANY SNAPSHOT (2023) 164
FIGURE 37 COLOPLAST GROUP: COMPANY SNAPSHOT (2024) 168
FIGURE 38 SMITH+NEPHEW: COMPANY SNAPSHOT (2024) 171
FIGURE 39 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2023) 176
FIGURE 40 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 180
FIGURE 41 B. BRAUN SE: COMPANY SNAPSHOT (2023) 184
FIGURE 42 ESSITY AKTIEBOLAG: COMPANY SNAPSHOT (2024) 187
FIGURE 43 PAUL HARTMANN AG: COMPANY SNAPSHOT (2023) 190
FIGURE 44 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023) 193
FIGURE 45 MATIV HOLDINGS, INC.: COMPANY SNAPSHOT (2024) 196
FIGURE 46 OWENS & MINOR: COMPANY SNAPSHOT (2024) 199
FIGURE 47 AVERY DENNISON CORPORATION: COMPANY SNAPSHOT (2024) 203
MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | USD9,150 | USD9,650 | USD11,500 |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- UV安定剤市場 – 2030年までの世界予測 2025-05-16
- 産業用通信市場 – 2030年までの世界予測 2025-05-16
- 経腸栄養装置市場 – 2030年までの世界予測 2025-05-15
- データセンターGPU市場 – 2030年までの世界予測 2025-05-15
- ステンレス鋼シームレスパイプ市場 – 2030年までの世界予測 2025-05-15